🇺🇸 FDA
Pipeline program

TBPM-PI-HBr

SPR994-301

Phase 3 small_molecule completed

Quick answer

TBPM-PI-HBr for Complicated Urinary Tract Infection is a Phase 3 program (small_molecule) at Spero Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Spero Therapeutics
Indication
Complicated Urinary Tract Infection
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials